SCHEMBL25820541

SCHEMBL25820541

N#Cc1ccc2nccc(Nc3ccnc(C(=O)Nc4cccc(Nc5ccccc5)c4)c3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.53
DNMT1 P26358 5/20 0.50
DNMT3A Q9Y6K1 5/20 0.50
MAPKAPK2 P49137 2/20 0.48
GAK O14976 1/20 0.47
RIPK2 O43353 1/20 0.47
COQ8A Q8NI60 1/20 0.47
NLK Q9UBE8 1/20 0.47
BRAF P15056 2/20 0.46
CCNC P24863 1/20 0.46
CDK8 P49336 1/20 0.46
DNMT3L Q9UJW3 3/20 0.44
EGFR P00533 2/20 0.44
EHMT1 Q9H9B1 1/20 0.43
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
KDR P35968 1/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24010218 0.95 DNMT1 (0.49) GRM4DNMT1DNMT3AMAPKAPK2GAK
SCHEMBL30290827 0.95 DNMT1 (0.49) GRM4DNMT1DNMT3AMAPKAPK2GAK
SCHEMBL25820730 0.89 DNMT1 (0.64) GRM4DNMT1DNMT3AMAPKAPK2GAK
SCHEMBL24003789 0.89 DNMT1 (0.59) DNMT1DNMT3AMAPKAPK2GAKRIPK2
SCHEMBL24010972 0.89 DNMT1 (0.64) GRM4DNMT1DNMT3AMAPKAPK2GAK
SCHEMBL24006215 0.88 MAPT (0.55) GRM4DNMT1DNMT3AMAPKAPK2GAK
SCHEMBL25820547 0.88 GRM4 (0.50) GRM4DNMT1DNMT3AMAPKAPK2GAK
SCHEMBL24003814 0.87 DNMT1 (0.49) GRM4DNMT1DNMT3AMAPKAPK2GAK
SCHEMBL25487871 0.86 DNMT1 (0.59) DNMT1DNMT3AMAPKAPK2GAKRIPK2
SCHEMBL24006195 0.86 DNMT1 (0.62) DNMT1DNMT3AMAPKAPK2GAKRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA GRM4 2605/4885DNMT1 4335/4885DNMT3A 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.